MedPath

Clinical Performance of a Chlorhexidine Antimicrobial Dressing

Phase 2
Completed
Conditions
Catheterization
Interventions
Drug: Transparent Adhesive Dressing
Registration Number
NCT00516906
Lead Sponsor
Solventum US LLC
Brief Summary

Evaluate the clinical performance of a new IV Dressing in Comparison to a standard IV Dressing

Detailed Description

Prospective, controlled, randomized, clinical trial comparing the 3M™ TegadermTM CHG (Chlorhexidine Gluconate) IV Securement Dressing (3M Healthcare, St Paul, MN) to a standard transparent dressing.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • Males or Females over 18 years of age
  • Patients with an existing, or newly inserted, central venous catheter
  • Patients who require the catheter for at least 3 days
Exclusion Criteria
  • Sensitivity to chlorhexidine

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Transparent Adhesive DressingTransparent Adhesive DressingStandard of Care Non-Antimicrobial Transparent Adhesive Dressing
CHG antimicrobial transparent dressingChlorhexidine gluconateChlorhexidine gluconate antimicrobial transparent adhesive dressing
Primary Outcome Measures
NameTimeMethod
Clinician Overall Satisfaction With Catheter SecurementDaily up to 7 Days (average 3-7 days of wear)

Clinician Overall Satisfaction with Catheter Securement Five Point Scale: 1 = Very Good, 5= Very Poor

Secondary Outcome Measures
NameTimeMethod
Clinician Overall Satisfaction With DressingDaily up to 7 Days (average 3-7 days of wear)

Clinician Overall Satisfaction with Dressing Five point scale: 1= Very Good, 5= Very poor

Rating of Skin ConditionDaily up to 7 Days (average 3-7 days of wear)

Ratings of skin condition for erythema on a 0 to 3 scale (0 = None, 1=Mild, 2=Moderate, 3=Severe)

© Copyright 2025. All Rights Reserved by MedPath